[1] Yip WC, Hsiao WC, Chen W, et al. Early appraisal of China's huge and complex health-care reforms [J]. Lancet, 2012,379(9818): 833-842.
[2] Newhouse JP. Medical-care expenditure: a cross-national survey [J]. J Hum Resour, 1977,12(1): 115-125.
[3] Halici-Tuluce NS, Dogan I, Dumrul C. Is income relevant for health expenditure and economic growth nexus? [J]. Int J Health Econ Manag, 2016,16(1): 23-49.
[4] Harris A, Sharma A. Estimating the future health and aged care expenditure in Australia with changes in morbidity [J]. PLoS One, 2018,13(8): e0201697.
[5] Kocot E. The impact of aging on different types of health care: The example of the Polish health insurance system [J]. Int J Health Plann Manage, 2018,33(2): e557-e568.
[6] Freeland MS, Schendler CE. National health expenditure growth in the 1980's: an aging population, new technologies, and increasing competition [J]. Health Care Financ Rev, 1983,4(3): 1-58.
[7] Zhai T, Goss J, Li J. Main drivers of health expenditure growth in China: a decomposition analysis [J]. BMC Health Serv Res, 2017,17(1): 185.
[8] Gerdtham UG, Sogaard J, Jonsson B, et al. A pooled cross-section analysis of the health care expenditures of the OECD countries [J]. Dev Health Econ Public Policy, 1992,1: 287-310.
[9] Gerdtham UG, Jonsson B, MacFarlan M, et al. The determinants of health expenditure in the OECD countries: a pooled data analysis [J]. Dev Health Econ Public Policy, 1998,6: 113-134.
[10] Okunade AA, Karakus MC, Okeke C. Determinants of health expenditure growth of the OECD countries: jackknife resampling plan estimates [J]. Health Care Manag Sci, 2004,7(3): 173-183.
[11] Herwartz H, Theilen B. Health care and ideology: a reconsideration of political determinants of public healthcare funding in the OECD [J]. Health Econ, 2014,23(2): 225-240.
[12] Wang F. More Health Expenditure, Better Economic Performance? Empirical Evidence From OECD Countries [J]. Inquiry, 2015,52.
[13] Nghiem SH, Connelly LB. Convergence and determinants of health expenditures in OECD countries [J]. Health Econ Rev, 2017,7(1): 29.
[14] Herwartz H, Theilen B. The determinants of health care expenditure: testing pooling restrictions in small samples [J]. Health Econ, 2003,12(2): 113-124.
[15] Cheng H. WHY PANEL DATA? [J]. Singapore Economic Review, 2012,50(02): 143-154.
[16] McNamara KA, Knox RVLYA, Kim YH, et al. Estimating Distributed Lags in Short Panels with an Application to the Specification of Depreciation Patterns and Capital Stock Constructs [J]. Social Science Electronic Publishing, 1984,51(2): 243-262.
[17] ChengHsiao, Mountain D, KathleenHoIllman. A Bayesian Integration of End-Use Metering and Conditional-Demand Analysis [J]. Journal of Business & Economic Statistics, 1995,13(3): 315-326.
[18] Park BU, Song SH. Comments on: Panel data analysis—advantages and challenges [J]. Test, 2007,16(1): 47-51.
[19] Meng Q, Yin D, Mills A, et al. China’s encouraging commitment to health [J]. BMJ, 2019, 365 :l4178.
[20] Yip, W. C., Hsiao, W. C., Chen, W., Hu, S., Ma, J., & Maynard, A. Early appraisal of China's huge and complex health-care reforms[J]. Lancet, 2012,379(9818), 833-842.
[21] Blundell R, Bond S. Initial conditions and moment restrictions in dynamic panel data models [J]. Economics Papers, 1998,87(1): 115-143.
[22] Arellano M, Bond S. Some Tests of Specification for Panel Data: Monte Carlo Evidence and an Application to Employment Equations [J]. Review of Economic Studies, 1991,58(2): 277-297.
[23] Roodman, D. . How to do Xtabond2: An Introduction to Difference and System GMM in Stata [J]. The Stata Journal,2009, 9(1), 86–136.
[24] Amiri A, Ventelou B. Granger causality between total expenditure on health and GDP in OECD: Evidence from the Toda–Yamamoto approach [J]. Economics Letters, 2012,116(3): 541-544.
[25] Younsi M, Chakroun M, Nafla A. Robust analysis of the determinants of healthcare expenditure growth: evidence from panel data for low-, middle- and high-income countries [J]. Int J Health Plann Manage, 2016,31(4): 580-601.
[26] Atilgan E, Kilic D, Ertugrul HM. The dynamic relationship between health expenditure and economic growth: is the health-led growth hypothesis valid for Turkey? [J]. Eur J Health Econ, 2017,18(5): 567-574.
[27] Gerdtham UG. The impact of aging on health care expenditure in Sweden [J]. Health Policy, 1993,24(1): 1-8.
[28] Dormont B, Grignon M, Huber H. Health expenditure growth: reassessing the threat of ageing [J]. Health Econ, 2006,15(9): 947-963.
[29] Lopreite M, Mauro M. The effects of population ageing on health care expenditure: A Bayesian VAR analysis using data from Italy [J]. Health Policy, 2017,121(6): 663-674.
[30] Hyun KR, Kang S, Lee S. Population Aging and Healthcare Expenditure in Korea [J]. Health Econ, 2016,25(10): 1239-1251.
[31] Seshamani M, Gray A. The impact of ageing on expenditures in the National Health Service [J]. Age Ageing, 2002,31(4): 287-294.
[32] Hitiris T, Posnett J. The determinants and effects of health expenditure in developed countries [J]. J Health Econ, 1992,11(2): 173-181.
[33] Mackenbach JP. Health care expenditure and mortality from amenable conditions in the European Community [J]. Health Policy, 1991,19(2-3): 245-255.
[34] Rothberg MB, Cohen J, Lindenauer P, et al. Little evidence of correlation between growth in health care spending and reduced mortality [J]. Health Aff (Millwood), 2010,29(8): 1523-1531.
[35] Lippi G, Mattiuzzi C, Cervellin G. No correlation between health care expenditure and mortality in the European Union [J]. Eur J Intern Med, 2016,32: e13-14.
[36] Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. The Lancet, 2019.